Replies to post #8399 on ANI Pharmaceuticals (ANIP)

[jeffqdhsr]

Hi Jadite

I agree in fact when I spoke to Art P several weeks ago he mentioned the focus in Corti and growth in sales near term for Asprin and other drugs they recently acquired how they can possibly greatly increase value short term

We also spoke about Libigel he made it clear it is not their focus and the conversation on this board is misguided , I gotta say he was very pleasant to speak to , we spent 1/2 hour or so on phone and offered to extend a invite to anyone that has questions to please feel free to call him.

Now with that being said the CVR s are good for 10 years they still remain in place , confirm all with him , JMHO